- Home
- FSBW vs GHRS Comparison
FSBW vs GHRS Comparison
Compare FSBW & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSBW
- GHRS
- Stock Information
- Founded
- FSBW 1936
- GHRS 2018
- Country
- FSBW United States
- GHRS Ireland
- Employees
- FSBW N/A
- GHRS N/A
- Industry
- FSBW Banks
- GHRS Biotechnology: Pharmaceutical Preparations
- Sector
- FSBW Finance
- GHRS Health Care
- Exchange
- FSBW Nasdaq
- GHRS Nasdaq
- Market Cap
- FSBW 355.0M
- GHRS 356.4M
- IPO Year
- FSBW 2012
- GHRS 2021
- Fundamental
- Price
- FSBW $40.75
- GHRS $8.88
- Analyst Decision
- FSBW Hold
- GHRS Strong Buy
- Analyst Count
- FSBW 1
- GHRS 3
- Target Price
- FSBW $44.00
- GHRS $35.67
- AVG Volume (30 Days)
- FSBW 15.0K
- GHRS 91.4K
- Earning Date
- FSBW 01-27-2025
- GHRS 02-27-2025
- Dividend Yield
- FSBW 2.65%
- GHRS N/A
- EPS Growth
- FSBW 8.77
- GHRS N/A
- EPS
- FSBW 4.68
- GHRS N/A
- Revenue
- FSBW $139,457,000.00
- GHRS N/A
- Revenue This Year
- FSBW N/A
- GHRS N/A
- Revenue Next Year
- FSBW $6.26
- GHRS N/A
- P/E Ratio
- FSBW $8.71
- GHRS N/A
- Revenue Growth
- FSBW 2.60
- GHRS N/A
- 52 Week Low
- FSBW $30.64
- GHRS $5.50
- 52 Week High
- FSBW $49.15
- GHRS $14.99
- Technical
- Relative Strength Index (RSI)
- FSBW 43.60
- GHRS 57.07
- Support Level
- FSBW $38.35
- GHRS $8.02
- Resistance Level
- FSBW $41.92
- GHRS $10.23
- Average True Range (ATR)
- FSBW 1.57
- GHRS 0.88
- MACD
- FSBW 0.20
- GHRS 0.10
- Stochastic Oscillator
- FSBW 57.04
- GHRS 60.06
About FSBW FS Bancorp Inc.
FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking, and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The company is focused on developing novel and proprietary Mebufotenin 5-Methoxy-N, N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.